A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of ThymoQuinone Formula (TQF) for Treating Outpatient SARS-CoV-2

There is an urgent need for an oral drug for the treatment of mild to moderate outpatient SARS-CoV-2. Our preclinical and clinical study’s aim was to determine the safety and preliminary efficacy of oral TQ Formula (TQF), in the treatment of outpatient SARS-CoV-2. In a double-blind, placebo-controll...

Descripción completa

Detalles Bibliográficos
Autores principales: Bencheqroun, Hassan, Ahmed, Yasir, Kocak, Mehmet, Villa, Enrique, Barrera, Cesar, Mohiuddin, Mariya, Fortunet, Raul, Iyoha, Emmanuel, Bates, Deborah, Okpalor, Chinedu, Agbosasa, Ola, Mohammed, Karim, Pondell, Stephen, Mohamed, Amr, Mohamed, Yehia I., Gok Yavuz, Betul, Kaseb, Mohamed O., Kasseb, Osama O., Gocio, Michelle York, Tu, Peter Tsu-Man, Li, Dan, Lu, Jianming, Selim, Abdulhafez, Ma, Qing, Kaseb, Ahmed O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144779/
https://www.ncbi.nlm.nih.gov/pubmed/35631072
http://dx.doi.org/10.3390/pathogens11050551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144779/
https://www.ncbi.nlm.nih.gov/pubmed/35631072
http://dx.doi.org/10.3390/pathogens11050551

Ejemplares similares